Avecho Biotechnology Limited (FRA:OEZ)

Avecho Biotechnology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 27, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22	5	7	18	18	29
Market Cap Growth	277.19%	-30.77%	-60.98%	-0.43%	-39.79%	640.32%
Enterprise Value	18	2	5	16	15	28
Last Close Price	0.01	0.00	0.00	0.01	0.01	0.01
PS Ratio	28.06	7.00	23.42	24.41	34.71	120.55
PB Ratio	46.94	2.42	1.74	11.37	6.07	17.47
P/TBV Ratio	46.94	2.42	1.74	11.49	6.21	20.85
P/OCF Ratio	32.51	-	-	-	-	-
EV/Sales Ratio	22.35	2.85	17.81	21.69	28.84	114.07
Debt / Equity Ratio	0.07	0.33	0.03	0.10	0.02	0.06
Debt / FCF Ratio	0.05	-	-	-	-	-
Asset Turnover	0.21	0.18	0.09	0.26	0.19	0.09
Inventory Turnover	4.46	3.93	2.07	1.12	1.93	1.16
Quick Ratio	4.46	2.70	7.83	2.97	6.31	3.90
Current Ratio	4.62	2.81	8.31	3.83	6.91	4.46
Return on Equity (ROE)	-143.71%	-64.72%	-78.08%	-67.30%	-95.01%	-71.08%
Return on Assets (ROA)	-33.53%	-31.11%	-40.10%	-33.99%	-49.50%	-40.56%
Return on Capital Employed (ROCE)	-61.90%	-93.30%	-52.80%	-89.80%	-74.90%	-102.30%
Earnings Yield	-9.35%	-39.40%	-30.98%	-8.50%	-12.40%	-5.68%
FCF Yield	-	-50.09%	-28.67%	-6.23%	-11.99%	-3.08%
Buyback Yield / Dilution	-9.80%	-39.73%	-23.41%	-1.97%	-13.27%	-0.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.